In the treatment of attention-deficit hyperactivity disorder ( ADHD ) , the efficacy of the tricyclic antidepressants and monoamine oxidase inhibitor antidepressants has been compared with that of both placebo and the stimulants ( methylphenidate and/or dextroamphetamine ) .
